Related references
Note: Only part of the references are listed.Dual-color photoacoustic lymph node imaging using nanoformulated naphthalocyanines
Changho Lee et al.
BIOMATERIALS (2015)
Pulmonary oil micro-embolism (POME) syndrome: a review and summary of a large case series
Robert J. Meyer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Reversible Micro- and Nano- Phase Programming of Anthraquinone Thermochromism Using Blended Block Copolymers
Yumiao Zhang et al.
LANGMUIR (2015)
Nanomedical engineering: shaping future nanomedicines
Dandan Luo et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines
Yumiao Zhang et al.
NATURE NANOTECHNOLOGY (2014)
Antiretroviral Solid Drug Nanoparticles with Enhanced Oral Bioavailability: Production, Characterization, and In Vitro-In Vivo Correlation
Tom O. McDonald et al.
ADVANCED HEALTHCARE MATERIALS (2014)
Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Preclinical Antitumor Activity of Cabazitaxel, a Semisynthetic Taxane Active in Taxane-Resistant Tumors
Patricia Vrignaud et al.
CLINICAL CANCER RESEARCH (2013)
Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20
Zsoka Weiszhar et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Impact of albumin on drug delivery - New applications on the horizon
Bakheet Elsadek et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology
Elaine Merisko-Liversidge et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspects
Joseph Wong et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Formation and enhanced biocidal activity of water-dispersable organic nanoparticles
Haifei Zhang et al.
NATURE NANOTECHNOLOGY (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Nanosizing - Oral formulation development and biopharmaceutical evaluation
Filippos Kesisoglou et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Use of whole sheep red blood cells in ELISA to assess immunosuppression in vivo
Ai Koganei et al.
JOURNAL OF IMMUNOTOXICOLOGY (2007)
DrugBank: a comprehensive resource for in silico drug discovery and exploration
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2006)
Albumin-bound paclitaxel: a next-generation taxane
William J. Gradishar
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
WJ Gradishar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cyclodextrins in drug delivery: An updated review
R Challa et al.
AAPS PHARMSCITECH (2005)
Drug delivery systems: Entering the mainstream
TM Allen et al.
SCIENCE (2004)
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX™/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
MER O'Brien et al.
ANNALS OF ONCOLOGY (2004)
Solubilizing excipients in oral and injectable formulations
RG Strickley
PHARMACEUTICAL RESEARCH (2004)
Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs
AN Lukyanov et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®):: PLGA nanoparticles containing vitamin E TPGS
L Mu et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Pharmacological effects of formulation vehicles - Implications for cancer chemotherapy
AJ ten Tije et al.
CLINICAL PHARMACOKINETICS (2003)
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
AV Kabanov et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2001)
Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future
RH Muller et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Biodegradable polymeric nanoparticles as drug delivery devices
KS Soppimath et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Relationship between pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes
MY Kozlov et al.
MACROMOLECULES (2000)
Effect of salts on the micellization, clouding, and solubilization behavior of pluronic F127 solutions
N Pandit et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2000)
Physicochemical aspects of drug delivery and release from polymer-based colloids
L Yang et al.
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2000)